Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders
出版年份 2012 全文链接
标题
Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume 8, Issue 2, Pages 115-129
出版商
Informa Healthcare
发表日期
2012-12-12
DOI
10.1517/17460441.2013.744746
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Propargylamine Containing Compounds as Modulators of Proteolytic Cleavage of Amyloid Protein Precursor: Involvement of MAPK and PKC Activation
- (2017) Orit Bar-Am et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections
- (2012) Wojciech Danysz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
- (2012) Sung-Jun Park et al. CELL
- Polycyclic Cage Structures as Lipophilic Scaffolds for Neuroactive Drugs
- (2012) Jacques Joubert et al. ChemMedChem
- Exploring the reactivity of flavonoid compounds with metal-associated amyloid-β species
- (2012) Xiaoming He et al. DALTON TRANSACTIONS
- Ironing out tau's role in parkinsonism
- (2012) Jeannette N Stankowski et al. NATURE MEDICINE
- Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
- (2012) Peng Lei et al. NATURE MEDICINE
- Protein–RNA interactions: new genomic technologies and perspectives
- (2012) Julian König et al. NATURE REVIEWS GENETICS
- Ebselen inhibits iron-induced tau phosphorylation by attenuating DMT1 up-regulation and cellular iron uptake
- (2012) Ling Xie et al. NEUROCHEMISTRY INTERNATIONAL
- Caffeine for treatment of Parkinson disease: A randomized controlled trial
- (2012) R. B. Postuma et al. NEUROLOGY
- Industrial toxicants and Parkinson's disease
- (2012) W. Michael Caudle et al. NEUROTOXICOLOGY
- Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease
- (2012) C. Laloux et al. PHARMACOLOGICAL RESEARCH
- Myricetin: A Naturally Occurring Regulator of Metal-Induced Amyloid-β Aggregation and Neurotoxicity
- (2011) Alaina S. DeToma et al. CHEMBIOCHEM
- Misfolded proteins in Alzheimer's disease and type II diabetes
- (2011) Alaina S. DeToma et al. CHEMICAL SOCIETY REVIEWS
- Natural Products of Dietary Origin as Lead Compounds in Virtual Screening and Drug Design
- (2011) Werner J. Geldenhuys et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Emerging adenosine receptor agonists – an update
- (2011) Zhan-Guo Gao et al. EXPERT OPINION ON EMERGING DRUGS
- Development of Bifunctional Stilbene Derivatives for Targeting and Modulating Metal-Amyloid-β Species
- (2011) Joseph J. Braymer et al. INORGANIC CHEMISTRY
- Privileged Scaffolds or Promiscuous Binders: A Comparative Study on Rhodanines and Related Heterocycles in Medicinal Chemistry
- (2011) Thomas Mendgen et al. JOURNAL OF MEDICINAL CHEMISTRY
- The emergence of designed multiple ligands for neurodegenerative disorders
- (2011) Werner J. Geldenhuys et al. PROGRESS IN NEUROBIOLOGY
- Identification of multifunctional small molecule-based reversible monoamine oxidase inhibitors
- (2011) Werner J. Geldenhuys et al. MedChemComm
- Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Antidiabetes Drugs
- (2011) Claudia Binda et al. ACS Medicinal Chemistry Letters
- Identification of novel monoamine oxidase B inhibitors by structure-based virtual screening
- (2010) Werner J. Geldenhuys et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Polyamine Conjugation of Curcumin Analogues toward the Discovery of Mitochondria-Directed Neuroprotective Agents†
- (2010) Elena Simoni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre-clinical systematic review
- (2010) Amanda T. White et al. JOURNAL OF NEUROCHEMISTRY
- The relevance of iron in the pathogenesis of Parkinson’s disease
- (2010) Jeswinder Sian-Hülsmann et al. JOURNAL OF NEUROCHEMISTRY
- R-Deprenyl: Pharmacological Spectrum of its Activity
- (2010) K. Magyar et al. NEUROCHEMICAL RESEARCH
- Design of small molecules that target metal-A species and regulate metal-induced A aggregation and neurotoxicity
- (2010) J.-S. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rasagiline: A novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity
- (2010) Orly Weinreb et al. PROGRESS IN NEUROBIOLOGY
- Structure–activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action
- (2009) Maria Laura Bolognesi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Oxo-bridged isomers of aza-trishomocubane sigma (σ) receptor ligands: Synthesis, in vitro binding, and molecular modeling
- (2009) Samuel D. Banister et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Alzheimer's disease: new approaches to drug discovery
- (2009) Maria L Bolognesi et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- MTDL Design Strategy in the Context of Alzheimers Disease: From Lipocrine to Memoquin and Beyond
- (2009) M. Bolognesi et al. CURRENT PHARMACEUTICAL DESIGN
- Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges
- (2009) Richard Morphy et al. CURRENT PHARMACEUTICAL DESIGN
- Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future
- (2009) Kian Fan Chung et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Investigation of the photostability properties of memoquin, a quinone derivative for the treatment of Alzheimer's disease
- (2009) Francesca Mancini et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Small Molecule Modulators of Copper-Induced Aβ Aggregation
- (2009) Sarmad S. Hindo et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease
- (2008) Pramod Kumar et al. BEHAVIOURAL BRAIN RESEARCH
- Dual inhibition of monoamine oxidase B and antagonism of the adenosine A2A receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues
- (2008) Judey Pretorius et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B
- (2008) L P Quinn et al. BRITISH JOURNAL OF PHARMACOLOGY
- The neuroprotective mechanism of action of the multimodal drug ladostigil
- (2008) Orly Weinreb Frontiers in Bioscience-Landmark
- Neuroprotective Effects of Resveratrol on MPTP-Induced Neuron Loss Mediated by Free Radical Scavenging
- (2008) Kwok-Tung Lu et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Crystal Structure of the Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligand Binding Domain Complexed with a Novel Partial Agonist: A New Region of the Hydrophobic Pocket Could Be Exploited for Drug Design
- (2008) Roberta Montanari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Memoquin: A multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer’s disease
- (2008) Maria Laura Bolognesi et al. Neurotherapeutics
- Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice
- (2008) Julie Blanchet et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Acteylcholinesterase inhibitor rivastigmine enhances cellular defenses in neuronal and macrophage-like cell lines
- (2008) Ximing Zhou et al. Translational Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started